Related Experiment Video
Updated: Jun 30, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Clearance for Driving in Genetic Generalized Epilepsy.
Jay Desai1,2, Kiarash Sadrieh1,2, Eesha Singh3
1Division of Neurology, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Assessing seizure control in genetic generalized epilepsy is crucial for driving suitability. Pediatric specialists show varied practices, highlighting the need for a standardized process to determine driving clearance.
Area of Science:
- Neurology
- Epilepsy Management
Background:
- Genetic generalized epilepsy (GGE) management requires evaluating seizure control.
- Determining fitness to drive is a critical aspect for patients with GGE.
Purpose of the Study:
- To survey child neurologists and pediatric epileptologists on key questions for driving clearance in GGE.
- To identify variability in current practices for assessing seizure control and driving suitability.
- To propose a standardized process for determining seizure control in GGE patients.
Main Methods:
- Survey distributed to child neurologists and pediatric epileptologists.
- Data collected on questions asked prior to providing driving clearance.
- Analysis of responses to identify common practices and variations.
Main Results:
- Significant variability in practice was observed among surveyed practitioners.
- Lack of consensus on essential questions for assessing driving suitability.
- Identified a need for a more consistent approach to managing GGE and driving.
Conclusions:
- Current practices for assessing driving suitability in GGE are highly variable.
- A standardized, evidence-based process is needed to ensure patient safety and informed decision-making.
- Further research and guideline development are recommended to address practice variations.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists